N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphinganine
|
K022803-250ug
|
99% |
114301-97-2 |
250ug
|
¥ 4804.0
|
4~8周 |
科威 |
Levitide
|
K022802-5mg
|
97% |
114281-19-5 |
5mg
|
¥ 1074.0
|
4~8周 |
科威 |
Levitide
|
K022802-2mg
|
97% |
114281-19-5 |
2mg
|
¥ 625.0
|
4~8周 |
科威 |
Levitide
|
K022802-1mg
|
97% |
114281-19-5 |
1mg
|
¥ 374.0
|
4~8周 |
科威 |
残杀威标准溶液
|
K018550-1ml
|
100μg/ml(u=2%,丙酮) |
114-26-1 |
1ml
|
¥ 132.0
|
4~8周 |
科威 |
(R)-Fluoxetine Hydrochloride
|
K022801-25mg
|
98% |
114247-09-5 |
25mg
|
¥ 4165.0
|
4~8周 |
科威 |
(R)-Fluoxetine Hydrochloride
|
K022801-5mg
|
98% |
114247-09-5 |
5mg
|
¥ 1141.0
|
4~8周 |
科威 |
(S)-Fluoxetine Hydrochloride
|
K022800-5mg
|
98% |
114247-06-2 |
5mg
|
¥ 1880.0
|
4~8周 |
科威 |
(S)-Fluoxetine Hydrochloride
|
K022800-25mg
|
98% |
114247-06-2 |
25mg
|
¥ 6853.0
|
4~8周 |
科威 |
N-苄氧羰基-L-丙氨酸
|
K018446-5g
|
98% |
1142-20-7 |
5g
|
¥ 51.0
|
现货 |
科威 |
N-苄氧羰基-L-丙氨酸
|
K018446-25g
|
98% |
1142-20-7 |
25g
|
¥ 101.0
|
现货 |
科威 |
N-苄氧羰基-L-丙氨酸
|
K018446-100g
|
98% |
1142-20-7 |
100g
|
¥ 272.0
|
8~10个工作日 |
科威 |
4,4''-二氯二苯二硫醚
|
K014710-5g
|
98% |
1142-19-4 |
5g
|
¥ 463.0
|
4~8周 |
科威 |
4,4''-二氯二苯二硫醚
|
K014710-25g
|
98% |
1142-19-4 |
25g
|
¥ 1382.0
|
4~8周 |
科威 |
1-Boc-3-羟甲基吡咯烷
|
K016134-1g
|
95% |
114214-69-6 |
1g
|
¥ 413.0
|
4~8周 |
科威 |
1-Boc-3-羟甲基吡咯烷
|
K016134-5g
|
95% |
114214-69-6 |
5g
|
¥ 1141.0
|
4~8周 |
科威 |
2,2''-二氨基二苯二硫醚
|
K017889-100g
|
98% |
1141-88-4 |
100g
|
¥ 807.0
|
现货 |
科威 |
2,2''-二氨基二苯二硫醚
|
K017889-25g
|
98% |
1141-88-4 |
25g
|
¥ 258.0
|
现货 |
科威 |
5-溴-4-氯-3-吲哚基-β-D-葡糖苷酸环己胺盐
|
K020045-500mg
|
99% |
114162-64-0 |
500mg
|
¥ 2088.0
|
现货 |
科威 |
5-溴-4-氯-3-吲哚基-β-D-葡糖苷酸环己胺盐
|
K020045-100mg
|
99% |
114162-64-0 |
100mg
|
¥ 709.0
|
现货 |
科威 |
5-溴-4-氯-3-吲哚基-β-D-葡糖苷酸环己胺盐
|
K020045-25mg
|
99% |
114162-64-0 |
25mg
|
¥ 210.0
|
现货 |
科威 |
4-(2-吡啶偶氮)间苯二酚
|
K018657-5g
|
AR |
1141-59-9 |
5g
|
¥ 124.0
|
现货 |
科威 |
2,3,6-三氟苯基乙酸
|
K004590-1g
|
97% |
114152-23-7 |
1g
|
¥ 292.0
|
4~8周 |
科威 |
2,6-萘二羧酸
|
K017169-5g
|
98% |
1141-38-4 |
5g
|
¥ 563.0
|
4~8周 |
科威 |